MYLAN 351

Pill imprint MYLAN 351 has been identified as Haloperidol 0.5 mg.

Haloperidol is used in the treatment of dementia; psychosis; nausea/vomiting; mania; tourette's syndrome (and more), and belongs to the drug class miscellaneous antipsychotic agents. Risk cannot be ruled out during pregnancy.

Haloperidol 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.

Haloperidol Images

Imprint:
MYLAN 351
Strength:
0.5 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Inactive Ingredients:
silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0351
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0733 UDL Laboratories Inc
18837-0348 Innoviant Pharmacy Inc (repackager)
68071-0494 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Haloperidol 0.5 mg MYLAN 351  Front
Haloperidol 0.5 mg MYLAN 351  Back
Haloperidol 0.5 mg MYLAN 351
Advertisement

Haloperidol is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web2)